BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Bi...
BioRestorative Therapies, Inc. today announced the successful completion of manufacturing for its BRTX-100 Phase 2 clinical trial.